Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2021-12-08
2022-06-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Affective Attentional Bias Training In Depression
NCT03106883
Gaze Contingent Feedback in Major Depressive Disorder (MDD)
NCT02945735
A Correlation Study of Cognitive Function in Patients With Depression
NCT05396989
An Eye Tracking Study of Affective Disorder Patients With Suicide Risk
NCT03711045
Evaluation of Use of Brain Activity Monitoring for Evaluation of Depression Treatment
NCT02523105
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Eye tracking
Utilisation of a eye tracker on a screen.
Eye tracker
Eye movements on a screen are captured with an eye tracker during a repeated measures before/after a directed autobiographical recall.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eye tracker
Eye movements on a screen are captured with an eye tracker during a repeated measures before/after a directed autobiographical recall.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men or women, aged 18 to 60
* patients without mental impairment
* patients without neurological impairment (epilepsy, encephalopathy, head trauma)
* patients with a sufficient command of French
* free patients, without guardianship or curators or subordination
* patients benefiting from coverage by a social security scheme or benefiting from it through a third party in accordance with the French law on biomedical research
* obtaining oral non-objection by the patient after clear and honest information about the study
* Patient with normal or corrected vision without rigid contact lenses
Exclusion Criteria
* patients aged \< 18 years or \> 60 years
* patients with mental impairment
* patients with neurological impairment (epilepsy, encephalopathy, head trauma)
* patients who do not speak French well enough
* patients hospitalized under duress
* patients without social security
* Patient wearing rigid contact lenses
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Henri Laborit
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Henri Laborit
Poitiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A01098-33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.